Lilly Dual-Acting Cymbalta Promoted By Dual Sales Force With Quintiles Deal

Lilly's use of a dual sales force for the antidepressant Cymbalta follows the Evista model

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet